Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH:ubiquinone oxidoreductase subunit A5 pseudogene 10 (NDUFA5P10) is a human pseudogene corresponding to a non-coding, non-functional copy of the gene for the A5 subunit of NADH:ubiquinone oxidoreductase (complex I of the mitochondrial respiratory chain)[[1]][[3]]. Pseudogenes like NDUFA5P10 do not encode functional proteins but may have regulatory roles through transcription into non-coding RNAs that can modulate the activity of protein-coding genes via mechanisms such as RNA interference or microRNA decoy function[[5]]. There is no evidence that this pseudogene is a therapeutic target, nor does it produce an active receptor, enzyme, transporter, or similar molecule. It is not known to be used as a biomarker, have interacting drugs, or present direct safety or therapeutic concerns. NDUFA5P10 is not a canonical drug target; it represents a noncoding genomic element with potential indirect biological effects but no protein product or targetable molecular function[[3]][[5]]. The presence and naming are correct, but as a pseudogene, it does not fit conventional definitions of a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit A5 pseudogene 10 (NDUFA5P10).